|
1
|
Global Burden of Disease Cancer
Collaboration; Fitzmaurice C, Dicker D, Pain A, Hamavid H,
Moradi-Lakeh M, MacIntyre MF, Allen C, Hansen G, Woodbrook R, Wolfe
C, et al: The Global Burden of Cancer 2013. JAMA Oncol. 1:505–527.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pennathur A, Gibson MK, Jobe BA and
Luketich JD: Oesophageal carcinoma. Lancet. 381:400–412. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tachimori Y, Ozawa S, Numasaki H,
Fujishiro M, Matsubara H, Oyama T, Shinoda M, Toh Y, Udagawa H and
Uno T; The Registration Committee for Esophageal Cancer of the
Japan Esophageal Society: Comprehensive Registry of Esophageal
Cancer in Japan, 2008. Esophagus. 12:130–157. 2015. View Article : Google Scholar
|
|
5
|
Akutsu Y, Uesato M, Shuto K, Kono T,
Hoshino I, Horibe D, Sazuka T, Takeshita N, Maruyama T, Isozaki Y,
et al: The overall prevalence of metastasis in T1 esophageal
squamous cell carcinoma: A retrospective analysis of 295 patients.
Ann Surg. 257:1032–1038. 2013. View Article : Google Scholar
|
|
6
|
Denzer K, Kleijmeer MJ, Heijnen HF,
Stoorvogel W and Geuze HJ: Exosome: From internal vesicle of the
multivesicular body to intercellular signaling device. J Cell Sci.
113:3365–3374. 2000.PubMed/NCBI
|
|
7
|
van den Boorn JG, Dassler J, Coch C,
Schlee M and Hartmann G: Exosomes as nucleic acid nanocarriers. Adv
Drug Deliv Rev. 65:331–335. 2013. View Article : Google Scholar
|
|
8
|
Takeshita N, Hoshino I, Mori M, Akutsu Y,
Hanari N, Yoneyama Y, Ikeda N, Isozaki Y, Maruyama T, Akanuman N,
et al: Serum microRNA expression profile: miR-1246 as a novel
diagnostic and prognostic biomarker for oesophageal squamous cell
carcinoma. Br J Cancer. 108:644–652. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Skog J, Würdinger T, van Rijn S, Meijer
DH, Gainche L, Sena-Esteves M, Curry WT Jr, Carter BS, Krichevsky
AM and Breakefield XO: Glioblastoma microvesicles transport RNA and
proteins that promote tumour growth and provide diagnostic
biomarkers. Nat Cell Biol. 10:1470–1476. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen WX, Liu XM, Lv MM, Chen L, Zhao JH,
Zhong SL, Ji MH, Hu Q, Luo Z, Wu JZ, et al: Exosomes from
drug-resistant breast cancer cells transmit chemoresistance by a
horizontal transfer of microRNAs. PLoS One. 9:e952402014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ichim TE, Zhong Z, Kaushal S, Zheng X, Ren
X, Hao X, Joyce JA, Hanley HH, Riordan NH, Koropatnick J, et al:
Exosomes as a tumor immune escape mechanism: Possible therapeutic
implications. J Transl Med. 6:372008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lundholm M, Schröder M, Nagaeva O, Baranov
V, Widmark A, Mincheva-Nilsson L and Wikström P: Prostate
tumor-derived exosomes down-regulate NKG2D expression on natural
killer cells and CD8+ T cells: Mechanism of immune
evasion. PLoS One. 9:e1089252014. View Article : Google Scholar
|
|
13
|
Hu Y, Yan C, Mu L, Huang K, Li X, Tao D,
Wu Y and Qin J: Fibroblast-derived exosomes contribute to
chemoresistance through priming cancer stem cells in colorectal
cancer. PLoS One. 10:e01256252015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ono M, Kosaka N, Tominaga N, Yoshioka Y,
Takeshita F, Takahashi RU, Yoshida M, Tsuda H, Tamura K and Ochiya
T: Exosomes from bone marrow mesenchymal stem cells contain a
microRNA that promotes dormancy in metastatic breast cancer cells.
Sci Signal. 7:ra632014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Walker ND, Patel J, Munoz JL, Hu M, Guiro
K, Sinha G, et al: The bone marrow niche in support of breast
cancer dormancy. Cancer Lett. Nov 3–2015.(Epub ahead of print).
pii: S0304–3835(15)00664-3. View Article : Google Scholar
|
|
16
|
An T, Qin S, Xu Y, Tang Y, Huang Y, Situ
B, Inal JM and Zheng L: Exosomes serve as tumour markers for
personalized diagnostics owing to their important role in cancer
metastasis. J Extracell Vesicles. 4:2752242015. View Article : Google Scholar
|
|
17
|
Savina A, Vidal M and Colombo MI: The
exosome pathway in K562 cells is regulated by Rab11. J Cell Sci.
115:2505–2515. 2002.PubMed/NCBI
|
|
18
|
Gupta S and Knowlton AA: HSP60 trafficking
in adult cardiac myocytes: Role of the exosomal pathway. Am J
Physiol Heart Circ Physiol. 292:H3052–H3056. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Usui A, Hoshino I, Akutsu Y, Sakata H,
Nishimori T, Murakami K, Kano M, Shuto K and Matsubara H: The
molecular role of Fra-1 and its prognostic significance in human
esophageal squamous cell carcinoma. Cancer. 118:3387–3396. 2012.
View Article : Google Scholar
|
|
20
|
Akanuma N, Hoshino I, Akutsu Y, Murakami
K, Isozaki Y, Maruyama T, Yusup G, Qin W, Toyozumi T, Takahashi M,
et al: MicroRNA-133a regulates the mRNAs of two invadopodia-related
proteins, FSCN1 and MMP14, in esophageal cancer. Br J Cancer.
110:189–198. 2014. View Article : Google Scholar :
|
|
21
|
Yodying H, Matsuda A, Miyashita M,
Matsumoto S, Sakurazawa N and Uchida E: Prognostic significance of
neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in
oncologic outcomes of esophageal cancer: A systematic review and
meta-analysis. Ann Surg Oncol. 23:646–654. 2016. View Article : Google Scholar
|
|
22
|
McMillan DC: The systemic
inflammation-based Glasgow Prognostic Score: A decade of experience
in patients with cancer. Cancer Treat Rev. 39:534–540. 2013.
View Article : Google Scholar
|
|
23
|
Tanaka Y, Kamohara H, Kinoshita K,
Kurashige J, Ishimoto T, Iwatsuki M, Watanabe M and Baba H:
Clinical impact of serum exosomal microRNA-21 as a clinical
biomarker in human esophageal squamous cell carcinoma. Cancer.
119:1159–1167. 2013. View Article : Google Scholar
|
|
24
|
Yoshioka Y, Kosaka N, Konishi Y, Ohta H,
Okamoto H, Sonoda H, Nonaka R, Yamamoto H, Ishii H, Mori M, et al:
Ultra-sensitive liquid biopsy of circulating extracellular vesicles
using ExoScreen. Nat Commun. 5:35912014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Suetsugu A, Honma K, Saji S, Moriwaki H,
Ochiya T and Hoffman RM: Imaging exosome transfer from breast
cancer cells to stroma at metastatic sites in orthotopic nude-mouse
models. Adv Drug Deliv Rev. 65:383–390. 2013. View Article : Google Scholar
|
|
26
|
Hoshino A, Costa-Silva B, Shen TL,
Rodrigues G, Hashimoto A, Tesic Mark M, Molina H, Kohsaka S, Di
Giannatale A, Ceder S, et al: Tumour exosome integrins determine
organotropic metastasis. Nature. 527:329–335. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fleitas T, Martínez-Sales V, Vila V,
Reganon E, Mesado D, Martín M, Gómez-Codina J, Montalar J and
Reynés G: Circulating endothelial cells and microparticles as
prognostic markers in advanced non-small cell lung cancer. PLoS
One. 7:e473652012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tavoosidana G, Ronquist G, Darmanis S, Yan
J, Carlsson L, Wu D, Conze T, Ek P, Semjonow A, Eltze E, et al:
Multiple recognition assay reveals prostasomes as promising plasma
biomarkers for prostate cancer. Proc Natl Acad Sci USA.
108:8809–8814. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Silva J, Garcia V, Rodriguez M, Compte M,
Cisneros E, Veguillas P, Garcia JM, Dominguez G, Campos-Martin Y,
Cuevas J, et al: Analysis of exosome release and its prognostic
value in human colorectal cancer. Genes Chromosomes Cancer.
51:409–418. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Quah B and O'Neill HC: Review: The
application of dendritic cell-derived exosomes in tumour
immunotherapy. Cancer Biother Radiopharm. 15:185–194. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Robbins PD and Morelli AE: Regulation of
immune responses by extracellular vesicles. Nat Rev Immunol.
14:195–208. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
King HW, Michael MZ and Gleadle JM:
Hypoxic enhancement of exosome release by breast cancer cells. BMC
Cancer. 12:4212012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Parolini I, Federici C, Raggi C, Lugini L,
Palleschi S, De Milito A, Coscia C, Iessi E, Logozzi M, Molinari A,
et al: Microenvironmental pH is a key factor for exosome traffic in
tumor cells. J Biol Chem. 284:34211–34222. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ban JJ, Lee M, Im W and Kim M: Low pH
increases the yield of exosome isolation. Biochem Biophys Res
Commun. 461:76–79. 2015. View Article : Google Scholar : PubMed/NCBI
|
